Intuitive Surgical, Inc. $ISRG Shares Bought by Czech National Bank

Czech National Bank grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 93,476 shares of the medical equipment provider’s stock after buying an additional 2,430 shares during the quarter. Czech National Bank’s holdings in Intuitive Surgical were worth $52,941,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Riversedge Advisors LLC increased its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after acquiring an additional 17 shares during the period. Fiduciary Financial Group LLC lifted its position in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares during the period. Prosperity Consulting Group LLC boosted its holdings in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares in the last quarter. Rossmore Private Capital boosted its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares in the last quarter. Finally, Activest Wealth Management increased its position in Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $469.98 on Thursday. The stock has a market cap of $166.90 billion, a P/E ratio of 59.57, a P/E/G ratio of 3.64 and a beta of 1.66. The stock’s 50 day simple moving average is $497.60 and its 200 day simple moving average is $513.35. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.21 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. The trade was a 16.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 32,943 shares of company stock valued at $17,279,568. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. HSBC increased their target price on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a research report on Wednesday, March 11th. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Finally, Evercore lowered their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research note on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $614.95.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street analysts remain broadly constructive on ISRG, with the average brokerage recommendation favoring buy/hold and continued sell‑side support that can underpin demand for the shares. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
• Positive Sentiment: Strategic expansion: ISRG is taking direct control of da Vinci and Ion distribution in Southern Europe, aiming to improve system availability, service and hospital access — a move that can drive recurring revenue and tighter customer relationships in a key geography. Intuitive Surgical Extends Southern Europe Reach As Stock Trades Below Targets
• Neutral Sentiment: Margins and tariff headwinds: Q4 margin compression was noted (margins ~37%), but management offset some pressure via cost efficiencies and strong recurring revenue — this tempers the near‑term outlook while leaving long‑term profitability intact if cost actions hold. ISRG’s Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
• Neutral Sentiment: Investor attention and stock trend pieces are increasing visibility on ISRG (more searches and “trending” writeups), which can boost liquidity but also amplify volatility as opinion pieces circulate. Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Short‑interest reporting appears inconsistent in recent feeds (large reported increases but values show zero/NaN); this data should be treated cautiously until confirmed by exchange filings. (No reliable link available.)
• Negative Sentiment: Recent share weakness: ISRG has underperformed recently (shares have moved lower vs. the market), and periodic selloffs amplify short‑term downside risk while investors wait for clearer signs that tariff and margin headwinds have stabilized. Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.